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Aims: To evaluate the capability of the exopolysaccharides (EPS) produced by lactobacilli and 26 
bifidobacteria from human and dairy origin to antagonize the cytotoxic effect of bacterial toxins. 27 
Methods and results: The cytotoxicity of Bacillus cereus extracellular factors on Caco-2 28 
colonocytes in the presence/absence of the EPS was determined by measuring the integrity of the 29 
tissue monolayer and the damage to the cell membrane (extracellular lactate-dehydrogenase 30 
activity). Additionally, the protective effect of EPS against the haemolytic activity of the 31 
streptolysin-O was evaluated on rabbit erythrocytes. The EPS produced by Bifidobacterium 32 
animalis subsp. lactis A1 and IPLA-R1, Bifidobacterium longum NB667 and Lactobacillus 33 
rhamnosus GG were able to counteract the toxic effect of bacterial toxins on the eukaryotic cells 34 
at 1 mg/ml EPS-concentration. The EPS A1 was the most effective in counteracting the effect of 35 
B. cereus toxins on colonocytes, even at lower doses (0.5 mg/ml), whereas EPS NB667 elicited 36 
the highest haemolysis reduction on erythrocytes. 37 
Conclusions: The production of EPS by lactobacilli and bifidobacteria in the intestinal 38 
environment could antagonize the toxicity of bacterial pathogens, this effect being EPS and 39 
biological marker dependent.     40 
Significance and impact of the study: This work allows gaining insight about the mechanisms 41 
that probiotics could exert to improve the host health. 42 
 43 
 44 
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INTRODUCTION  47 
  Exopolysacharides (EPS) are extracellular biopolymers that are produced by many lactic 48 
acid bacteria (LAB) and other bacteria present in fermented foods and human environments such 49 
as propionibacteria and bifidobacteria (Ruas-Madiedo et al., 2009b). In fact, the EPS-producing 50 
strains are used in the dairy industry because of the ability of their polymers to act as biological 51 
stabilizers, viscosifiers, emulsifiers and gelling agents (Abraham et al., 2009; Behare et al., 52 
2009). In addition, in recent years several health benefits have been attributed to EPS from LAB 53 
(Ruas-Madiedo et al., 2008).  54 
The ecological role of EPS for the producing bacteria is not completely understood. It has 55 
been reported that they could be involved in cell recognition, adhesion to surfaces and biofilm 56 
formation, which would enhance the colonization of different ecosystems (Ruas-Madiedo et al., 57 
2008). In this regard, it has been proposed that EPS produced by intestinal lactobacilli and 58 
bifidobacteria could be involved in the adherence to intestinal mucus and also in the interaction 59 
with enteropathogens (Ruas-Madiedo et al., 2006). Also, EPS produced by bifidobacteria are able 60 
to modulate the intestinal microbiota by acting as fermentable substrates (Salazar et al., 2008, 61 
2009b). On the other hand, bacterial EPS could counteract the activity of bacteriophages (Durlu-62 
Özkaya et al, 2007) and of toxic compounds (Looijestein et al., 2001; Kim et al., .2006). 63 
The synthesis of EPS in the gut ecosystem could confer a selective advantage for the 64 
survival and colonization of this niche by the producing bacteria. Indeed, EPS could improve the 65 
survival throughout the gastrointestinal tract of orally delivered bacteria given that bile is able to 66 
induce the synthesis of these polymers in Bifidobacterium animalis (Ruas-Madiedo et al., 2009a).  67 
In the gut environment it has also been reported that kefiran, the EPS produced by LAB in the 68 
fermented milk kefir, is able to antagonize the biological activity of Bacillus cereus and also their 69 
extracellular factors on Caco-2 colonocytes (Medrano et al., 2008, 2009).  However, there is no 70 































































evidence as to whether EPS produced by lactobacilli and bifidobacteria from intestinal origin are 71 
able to exert similar protective effects against the activity of bacterial toxins.  72 
The aim of this work was to evaluate the effect of the EPS produced by the strains 73 
Lactobacillus rhamnosus GG, Bifidobacterium longum NB667, Bif. animalis subsp. lactis A1 and 74 
IPLA-R1 on the biological activity triggered by bacterial toxins (extracellular factors of B. cereus 75 
and streptolysin-O (SLO) from Streptococcus pyogenes) on different eukaryotic cell models 76 
(Caco-2 cells and rabbit erythrocytes).  77 
 78 
MATERIALS AND METHODS 79 
Bacterial strains and culture conditions  80 
The bacterial strains used in this study are shown in Table 1. Stock cultures of B. cereus 81 
B10502 were stored at -80°C in BHI (Biokar Diagnostics, Beauvais, France) using glycerol 1% 82 
(v/v) as cryo-protective agent. The strain was reactivated in BHI supplemented with glucose 83 
0.1% (w/v) for 16 h at 32°C in an orbital shaker and these cultures were used to inoculate (4% 84 
v/v) 5 ml of fresh BHI-glucose which was incubated under the same conditions. Cell-free 85 
supernatants were obtained after centrifugation (900×g, 10 min) and filtration (0.45 µm). Serial 86 
dilutions of supernatants were made in phosphate-buffered saline (PBS: KH2PO4 0.144 g/L, 87 
Na2HPO4 0.795 g/L and NaCl 9 g/L). 88 
The four EPS-producing lactobacilli and bifidobacteria strains (Table 1) were maintained 89 
at -80ºC in MRSC broth [MRS (Biokar) + 0.25% (w/v) L-cysteine (Sigma Chemical Co., St. 90 
Louis, MO, USA)] with 20% glycerol. For the isolation of EPS, frozen stocks were grown 91 
overnight at 37°C under anaerobic atmosphere (10% H2, 10% CO2, and 80% N2) in a Mac500 92 
chamber (Down Whitley Scientific, West Yorkshire, UK). Cultures (200 µl) were used to 93 































































inoculate agar-MRSC plates using sterile glass beads. Plates were incubated for 5 days at 37ºC in 94 
anaerobic conditions.  95 
Isolation and characterization of the EPS 96 
For the isolation of the EPS, cell biomass was collected from agar-MRSC plates using 2 97 
ml ultrapure water per plate and the resulting volume was mixed with 1 vol of 2 M NaOH. The 98 
suspension was gently stirred overnight at room temperature to promote polymer release and 99 
afterwards cells were removed by centrifugation (8400×g, 30 min). The EPS-fraction was 100 
precipitated using 2 volumes of cold-absolute ethanol (4°C, 48 h), followed by centrifugation, 101 
resuspension in ultrapure water and dialysis for 3 days at 4°C with a daily change of water using 102 
dialysis tubes (Sigma) of 12 to 14 kDa molecular mass cut off. Finally, the dialysed EPS were 103 
freeze-dried (Ruas-Madiedo et al., 2006).  104 
The protein content of the EPS-fractions was determined by the BCA protein assay kit 105 
(Pierce, Rockford, IL, USA). The molar mass (MM) and radius of gyration (Rg) of the EPS were 106 
measured by size-exclusion chromatography and multiangle laser light scattering detection (SEC-107 
MALLS, Salazar et al., 2009b). The monosaccharide composition was determined by GC-MS 108 
(Salazar et al., 2009a). The phosphate content of each EPS was directly measured in an atomic 109 
emission spectroscopy Perkin Elmer 5500 inductively coupled plasma (Perkin Elmer, Norwalk, 110 
CT, USA) at the “Centro de Ciencias Medioambientales” (CCM-CSIC, Madrid).  111 
Each EPS was resuspended in PBS solution at 20 mg/ml and several dilutions ranging 112 
from 0.05 to 1 mg/ml were used for experiments.  113 
 114 
Culture of human Caco-2 cell line 115 
Caco-2 cells were routinely grown in Dulbecco’s modified Eagle’s medium (DMEM) 116 
containing 25 mM glucose (GIBCO BRL Life Technologies Rockville, MD USA), supplemented 117 































































with 15% (v/v) heat-inactivated (30 min at 56°C) foetal calf serum (PAA Laboratories GmbH, 118 
Pasching, Austria), 1% (v/v) nonessential amino acids (PAA Laboratories GmbH), penicillin (12 119 
UI/ml), streptomycin (12 µg/ml), gentamicin (50 µg/ml) and fungizone (1.25 µg/ml). For 120 
maintenance purposes, the cell line was passed weekly, using 0.02% (w/v) trypsin (Sigma) in 121 
PBS containing 3 mM EDTA. Cell suspensions (1x105 cells/ml) were seeded in 6- or 24-well 122 
plates (Greiner Bio One, Germany) and incubated to form confluent-differentiated monolayers 123 
for 14±1 d at 37°C in a 5% CO2 atmosphere. The culture medium was changed every 2 days and 124 
the experiments were perf rmed with cells among passages 56 and 60.  125 
Detachment of Caco-2 cells  126 
The integrity of the Caco-2 monolayers was determined by measuring the cell detachment 127 
as previously reported by Minnaard and co-workers (2001). Briefly, differentiated cells grown in 128 
24-well plates were co-incubated with several dilutions (from 1/2 to 1/64) of B. cereus B10502 129 
supernatants at 37°C in 5% CO2 atmosphere for 150 min in presence of different EPS 130 
concentrations (0, 0.05, 0.5 and 1 mg/ml). After incubation, Caco-2 cells were washed with PBS, 131 
fixed for 1 minute with 2% (w/v) formaldehyde in PBS and washed again. Staining was 132 
performed with 500 µl of crystal violet solution [0.13% crystal violet, 5% ethanol, and 2 % 133 
formaldehyde (w/v/v) in PBS] by incubating for 20 min. Afterwards stain excess was washed 134 
with PBS and samples were treated for one hour with 50 % (v/v) ethanol. Absorbance of stained 135 
cells was measured at 590 nm in a Metrolab 330 spectrophotometer (Metrolab, Buenos Aires, 136 
Argentina). The percentage of attached cells was calculated as the absorbance of treated cells 137 
with respect to the absorbance of untreated-control cells (suspended in PBS and incubated in the 138 
absence of B. cereus supernatant and EPS).  139 































































Lactate dehydrogenase activity in Caco-2 cells 140 
Caco-2 cell membrane integrity was determined by measuring the extracellular lactate 141 
dehydrogenase (LDH) activity using the LDH-P unitest kit (Weiner Lab, Rosario, Argentina) 142 
following the manufacturer’s specifications. Differentiated Caco-2 cells grown in 6-well plates 143 
were co-incubated with serial dilutions (1/16 to 1/32) of B. cereus B10502 cell-free supernatants 144 
in the presence (1 mg/ml) and absence of bacterial EPS at 37°C in 5% CO2 atmosphere for 2 h. 145 
The extracellular LDH activity was determined by mixing 50 µl of Caco-2 supernatants with the 146 
enzyme substrate and incubating at 30ºC. Absorbance at 340 nm was measured continuously 147 
during 120 s in a spectrophotometer Beckman DU650 (Beckman, CA, USA) and LDH activity 148 
was calculated as the decrease of absorbance for 60 seconds.  149 
Haemolysis of erythrocytes  150 
The putative protective effect of EPS against the toxic activity of SLO from S. pyogenes 151 
upon erythrocytes was assessed according to Promdonkoy and Ellar (2003). Commercial SLO 152 
(Sigma) was diluted in PBS containing 20 mM L-cystein, adjusted to pH 7.4, filtered and mixed 153 
with (2% v/v) rabbit erythrocytes suspended in PBS. Toxin units used in the experiments were 154 
around 300 UI enzyme/ml [one unit is defined as the amount of enzyme able to cause 50% lysis 155 
of 50 µl of  2% (v/v) red blood suspension in PBS, pH 7.4 at 37°C in 30 min]. Erythrocyte 156 
suspensions were co-incubated with SLO in the presence (1 mg/ml) and absence of the EPS at 157 
37°C for 60 min. Two control samples were used: 0% lysis (erythrocytes in absence of SLO 158 
toxin) and 100% lysis [erythrocytes treated with 0.2% Triton X-100 (Sigma) in PBS]. 159 
Absorbance decrease of erythrocyte suspensions was measured at 600 nm in a Metrolab 330 160 
spectrophotometer at different sampling points for 60 min. The percentage of remaining (not 161 
lysed) erythrocytes in the samples was calculated as follows: 100*(Absorbance of sample - 162 































































Absorbance of 100% lysis control) / (Absorbance of 0% lysis control - Absorbance of 100% lysis 163 
control).  164 
Statistical analysis  165 
All experiments have been carried out at least in triplicate. Statistical analysis was 166 
performed using the SPSS-PC 11.0 software (SPSS Inc., Chicago, Illinois, USA). Data were 167 
subjected to a one-way ANOVA and the least significant difference test (LSD) was used for the 168 
subsequent comparison of means. For the haemolysis data and within each type of EPS-sample, a 169 
paired samples t-test was performed to compare the percentage of remaining erythrocytes after 60 170 
min of incubation with respect to the initial values.  171 
 172 
RESULTS   173 
Physico-chemical characteristics of the bacterial EPS 174 
Table 2 shows the protein content, MM distribution and chemical composition of the EPS 175 
analysed. The protein content of the EPS was in general lower than 3% indicating high 176 
carbohydrate content and thus a good degree of purity of the polymer. L. rhamnosus GG 177 
synthesised a unique peak of 2.2x105 Da. However, the EPS synthesised by Bifidobacterium 178 
strains (A1, IPLA-R1 and NB667) presented more than one peak of different MM. The EPS 179 
produced by Bif. longum NB667 had two polymer fractions, one of low (4.3 x103 Da) MM and 180 
another of high (4.4 x106 Da) MM. Bif. animalis subsp. lactis A1 and IPLA-R1 are closely 181 
related strains. A bile resistant derivative strain (A1dOx) was obtained from the parental A1 by 182 
gradual adaptation to bile salts. This bile-adapted strain converted spontaneously to a stable ropy 183 
phenotype by successive sub-cultivation resulting in the strain IPLA-R1. The ropy phenotype of 184 
IPLA-R1 strain is absent in the parental A1 and these two strains produced polymers differing in 185 
MM and peak distribution (Table 2). Both strains share two EPS-fractions of low MM (around 186 































































3x104 and 5x103 Da) but IPLA-R1 is able to additionally produce, in high amounts (56%), an 187 
EPS of high (3.5 x106 Da) MM, probably being responsible for the ropy character. The EPS 188 
produced by these closely related strains also differed in their monosaccharide ratio composition. 189 
The EPS-fraction A1 showed a higher glucose and galactose, and lower rhamnose, ratio than 190 
IPLA-R1. Although EPS NB667 and GG also have the same monomers in their composition, the 191 
ratio among the four polymers was different. It is worth noting that EPS A1 and IPLA-R1 also 192 
have phosphate in their composition, which was not detected in NB667 and GG. Finally, 193 
variations in the Rg of the highest MM peak of each EPS were also detected with values of 13, 194 
17, 47 and 67 nm for EPS GG, A1, IPLA-R1 and NB667, respectively. These results show a high 195 
variability in the physico-chemical characteristics of the bacterial EPS used in this study which 196 
could account for different biological effects.  197 
 198 
Effect of bacterial EPS against B. cereus citotoxicity on Caco-2 cells  199 
The protective effect of the bacterial EPS against the toxic effect of B. cereus extracellular 200 
factors on Caco-2 cells was determined by testing the integrity of Caco-2 cell monolayer. Fig. 1 201 
shows the Caco-2 cells that remained adhered to the surface of the well-plates after co-incubation 202 
with serial dilutions (1/16 to 1/64) of B. cereus supernatants in the presence (1 mg/ml) and 203 
absence of EPS. Under these experimental conditions, all EPS were able to significantly (p<0.05) 204 
antagonize the cell detachment triggered by B. cereus B10502 supernatants at the highest toxin 205 
concentration (dilution 1/16), the EPS A1 being able to display the highest protection. At B. 206 
cereus supernatant 1/32 and 1/64 dilutions the lower toxin concentration did not induce the 207 
detachment of the Caco-2 monolayers in the control (absence of EPS) samples and no differences 208 
with respect to the presence of the EPS were detected. Higher toxin concentrations (dilutions 1/2 209 
to 1/8, data not shown) caused the total detachment of the cells and no protection was observed 210 































































with any of the EPS assayed. Taking into account the above results, the EPS with the highest 211 
(EPS A1) and one of the lowest (IPLA-R1) antagonism capability against B. cereus supernatant 212 
toxicity on Caco-2 cells were chosen to study a putative dose-response effect of these EPS (Fig. 213 
2). For EPS A1, a significant (p<0.05) protection effect was detected at concentrations higher 214 
than 0.05 mg/ml whereas for EPS IPLA-R1 was detected only at 1 mg/ml. In addition, at the 215 
highest EPS concentration tested (1 mg/ml) the percentage of cells that remained adhered was 216 
significantly higher (p <0.001) for EPS A1 than for EPS IPLA-R1. Thus, the differential EPS-217 
characteristics may have account for this variability in the protective capability between both 218 
EPS.  219 
To evaluate Caco-2 cell membrane integrity, the extracellular release of LDH activity (a 220 
cytoplasmatic enzyme) was measured in the milieu of Caco-2 co-cultivated with B. cereus 221 
supernatant dilutions 1/16 and 1/32 in the presence (1 mg/ml) and absence of bacterial EPS (Fig. 222 
3). The four EPS tested showed significant differences (p<0.05) with respect to the control 223 
(absence EPS) sample at both toxin concentrations tested. The effect was also significant 224 
(p<0.001) at low toxin concentration (dilution 1/32). As similarly occurred when cell detachment 225 
was analysed, the EPS-fraction NB667 showed the lowest prot ctive effect of the four EPS 226 
analysed. Thus, this result suggests that bacterial EPS exerted a protective effect on Caco-2 cells 227 
by avoiding the loss of membrane integrity and/or the release of cytoplasmatic content.  228 
 229 
Effect of EPS against SLO toxin on erythrocyte cells 230 
The results presented above prompted us to study the effect of these EPS on the biological 231 
activity of large-pore forming toxins. Rabbit erythrocytes were employed to evaluate the putative 232 
protection of bacterial EPS against the haemolytic activity of the commercial bacterial 233 
haemolysin SLO. Kinetics of haemolysis performed in the presence (1 mg/ml) and absence of the 234 































































EPS under study are depicted in Fig. 4. The remaining erythrocytes of all samples significantly 235 
diminished with respect to the initial values after 60 min of erythrocyte co-incubation with the 236 
SLO toxin (paired t-test: p<0.001). However, when the EPS were added the rate of haemolysis 237 
decreased and significant differences were found at the end of the incubation period with respect 238 
to the sample in absence of EPS (p<0.05). It is worth noting that in the case of haemolysis, the 239 
EPS A1 displayed the lowest protection capability of the four EPS tested, whereas the EPS 240 
NB667 showed the highest. This represents an opposite tendency with respect to that observed 241 
for the model Caco-2 and extracellular toxins of B. cereus.  242 
 243 
DISCUSSION 244 
The capability of bacterial EPS to antagonize the membrane eukaryotic cell damage 245 
triggered by B. cereus extracellular factors and by SLO from S. pyogenes, was evaluated in two 246 
complementary cell models: colonocyte-like cells (Caco-2 cellular line) and rabbit erythrocytes. 247 
These bacterial toxins produce different effects upon eukaryotic cells. B. cereus can trigger in 248 
humans diverse symptoms related to their adhesion to the intestinal epithelium and invasion of 249 
enterocytes (Minnaard et al., 2004) and/or due to the production of a wide range of extracellular 250 
factors such as cytolisins (cereolisyn-O), phospholipases and hemolisyns, among others (Alouf, 251 
2000; Minnaard et al., 2007; Stenfors-Arnesen et al., 2008). The SLO belongs to the large-pore 252 
forming family of toxins (Alouf, 2000; Thelestam, 2000), in which is included the cereolysin-O 253 
from B. cereus. In this study we have shown that the EPS produced by strains of lactobacilli and 254 
bifidobacteria are able to counteract the toxic effect of bacterial toxins. However, the effect was 255 
different depending on the EPS considered and also on the biological (eukaryotic cell) marker 256 
studied. 257 































































In the case of the B. cereus supernatants, the EPS IPLA-R1 and NB667 showed the lowest 258 
protection capability by preventing the Caco-2 cell de-attachment and/or the LDH release. A 259 
common feature of these two polymers is the production of a high MM EPS fraction (>106 Da). 260 
The high MM fraction is not present in the EPS synthesised by strain A1 (parental strain of 261 
IPLA-R1) which exerted the highest protection, suggesting that the high MM fraction is not 262 
necessary to exert the protective effect against B. cereus toxins. Additionally, the protective 263 
effect of EPS A1 was detected at lower doses (0.5 mg/ml) than EPS IPLA-R1, and at the 264 
concentration of 1 mg/ml the EPS A1 elicited a significantly higher antagonic effect than IPLA-265 
R1. The medium MM (2.2x105 Da) EPS produced by GG strains had a biological effect closer to 266 
EPS A1. However, the kefiran isolated from the kefir grains, which is a branched glucogalactan 267 
with an MM higher than 107 Da (Piermaria et al., 2008), was able to significantly abrogate the 268 
cytotoxic effect of B. cereus toxins at similar concentrations (from 0.3 to 1 mg/ml, Medrano et 269 
al., 2008) than our EPS A1. Thus, the MM of a polymer is not the only determining factor 270 
involved in its protective capability. Also the chemical composition, type of union and the spatial 271 
structure of the EPS could be involved in the different biological effect. With respect to the 272 
putative mechanism against B. cereus toxins, the bacterial EPS could act by blocking the toxin 273 
receptors in the eukaryotic cell or by capturing the toxin, thus avoiding its interaction with the 274 
receptor. In both cases, the EPS would avoid the initiation of an intracellular cascade response 275 
that ends with the death, by necrosis or apoptosis, of the eukaryotic cell (Henderson et al., 1999).  276 
Regarding the antagonism of bacterial EPS against the haemolytic activity of SLO on 277 
erythrocytes, our EPS were able to diminish the rate of haemolysis. However, in this case the 278 
EPS A1 showed the lower percentage of protection and the EPS NB667 the highest; this is just 279 
the opposite behaviour of that detected for the Caco-2 / B. cereus toxins system. This finding 280 
suggested that the mechanism involved in haemolysis protection might be different to that 281 































































involved in cell detachment. One of the main mechanisms leading to haemolysis by haemolysins, 282 
such as SLO (and also the cereolysin-O from B. cereus), is the oligomerization and assembly of 283 
toxin monomers into the cytoplasmic membrane of eukaryotic cells thus forming large pores 284 
(Palmer et al., 1998; Henderson et al., 1999). The EPS produced by our bifidobacteria and 285 
lactobacilli might display their antagonism by hindering the contact of the toxin with the 286 
erythrocyte membrane; this will avoid the toxin-subunits oligomerization and pore formation, 287 
thus EPS could exert osmotic protection. In this way, MM and Rg are important structural 288 
characteristic of EPS to be considered. We observed that the lowest protection on haemolysis was 289 
obtained with EPS with low MM and Rg, this is the EPS A1.  290 
Thus it seems that polymers having small Rg and low MM might be able to better 291 
abrogate the cytotoxic effect of B. cereus toxins but are less effective for large-pore forming 292 
toxin such as SLO. The physical parameters and chemical composition of EPS are related to the 293 
structure of the repeating units that build the polymers. In our case, with the exception of EPS 294 
GG (Landersjö et al., 2002), the repeating units of EPS A1, IPLA-R1 and NB667 are still 295 
unknown. Thus, we do not have enough data to conclude that the MM and Rg are the unique 296 
parameters directly related to the anti-toxin effect of our EPS and to extend this conclusion to 297 
other bacterial EPS. However, it is well known that the physico-chemical characteristics of 298 
bacterial EPS are directly correlated with their technological and biological functionality 299 
(Ruijssenaars et al., 2000, Vaningelgem et al., 2004; Mozzi et al., 2009; Salazar et al., 2009a). 300 
Therefore, it seems that the physicochemical properties of the EPS would also determine the 301 
specific interactions with eukaryotic cell receptors and/or with toxins. 302 
 303 
CONCLUSIONS 304 































































The EPS synthesised by the human and dairy origin strains L. rhamnosus GG, Bif. longum 305 
NB667, Bif. animalis subsp. lactis A1, and its bile-adapted derivative IPLA-R1, are able to exert 306 
an antagonic effect against the cytophatic effect on Caco-2 cells triggered by B. cereus 307 
extracellular factors, and against the haemolytic activity of a large-pore forming toxin, such as 308 
SLO, on rabbit erythrocytes. Differences among EPS depended on the biological marker studied 309 
and could be attributed to the variability of the physico-chemical characteristics of these 310 
biopolymers. Although the protective mechanisms are still not fully understood, it is tempting to 311 
hypothesize that the bacterial EPS could act by blocking receptors on the eukaryotic cell surface 312 
or by acting as toxin-chelant agents. Nevertheless, the capability to abrogate the activity of 313 
bacterial toxins by EPS produced by lactobacilli and bifidobacteria is another mechanism 314 
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Table 1. Microorganism used in this study 412 
Species Strains  Origin * 
B. cereus B10502 Food poisoning outbreak (Minnaard et al., 2004) 
L. rhamnosus  GG (LMG18243) LMG Culture collection (human faces) 
Bif. animalis subsp. lactis A1 
IPLA-R1  
Isolated from commercial dairy product 
Bile-adapted strain from A1 (IPLA collection) 
Bif. longum NB667  NIZO Culture collection (infant faeces)  
 413 
*: LMG: Belgian Co-ordinated Collections of Microorganisms (Gent, Belgium) and NIZO Food 414 
Research Collection (Ede, The Netherlands) 415 
































































Table 2. Physico-chemical characteristics of the EPS used in this study 2 
 3 
 Protein  Molar mass (Da) distribution (%) *  Monosaccharide ratio †   
EPS (%)  Peak 1 Peak 2 Peak 3  Glc Gal Rham  PO4 
A1 3.1  - 2.8x104 (44%) 5.0x103 (56%)  2.5 2 1  + 
IPLA-R1 2.6  3.5x106 (56%) 3.0x104 (21%) 4.9x103 (23%)  1 1 1.5  + 
NB667 2.2  4.4x106 (47%) - 4.3x103 (53%)  1 2 1  - 
GG  2.9  - 2.2x105 (100%) -  1 4 1  - 
 4 
*: Percentage calculated with respect to the total amount (µg) of peaks measured by size-exclusion chromatography (SEC-MALLS). 5 
†: Glu, glucose; Gal, galactose; Rham: rhamnose 6 































































LEGENDS TO FIGURES 1 
Figure 1. Percentage of Caco-2 cells adhered to the well-plate after treatment with several 2 
dilutions (1/16, 1/32 and 1/64) of B. cereus B10502 supernatants in the absence (white 3 
bars) and presence (1 mg/ml) of the EPS isolated from the strains Bif. animalis subsp. lactis 4 
A1 and IPLA-R1, Bif. longum NB667 and L. rhamnosus GG (grey bars). The percentage of 5 
cells that remained attached was calculated as follows: 100*[590 nm-absorbance of treated 6 
samples / absorbance of control cells (incubated in absence of B. cereus supernatant)]. 7 
Within each supernatant dilution, the columns with different letters are statistically different 8 
(p<0.05) according to the LSD mean comparison test. 9 
 10 
Figure 2. Percentage of Caco-2 cells that remained adhered to the well-plate after the 11 
treatment with the dilution 1/16 of B. cereus B10502 supernatant in the presence of several 12 
concentrations of the EPS isolated from the strains Bif. animalis subsp. lactis A1 and IPLA-13 
R1. Concentrations: 0 ( ), 0.05 ( ), 0.5 ( ) and 1 ( ) mg/ml. Within each EPS, the columns 14 
that do not have a common superscript are statistically different (p<0.05) according to the 15 
LSD mean comparison test. At the highest concentration (1 mg/ml), a one-way ANOVA test 16 
was performed to analyse differences between both polymers (***, p <0.001). 17 
 18 
Figure 3. Extracellular LDH activity of Caco-2 cells after co-cultivation with B. cereus 19 
B10502 supernatants (dilutions 1/16 and 1/32) in the absence (white bars) and presence (grey 20 
bars) of the EPS (1 mg/ml) isolated from the strains Bif. animalis subsp. lactis A1 and IPLA-21 
R1, Bif. longum NB667 and L. rhamnosus GG. The LDH activity was calculated as the 22 
decrease in absorbance at 340 nm after 60 s of reaction. Within each B. cereus supernatant 23 































































dilution, the columns that have not a common superscript are statistically different (p<0.05) 1 
according to the LSD mean comparison test.  2 
 3 
Figure 4. Lysis kinetics of rabbit erythrocytes co-incubated with SLO toxin (300 UI) 4 
without EPS ( ), or with 1 mg/ml of EPS A1 ( ), EPS IPLA-R1 ( ), EPS GG (●) and EPS 5 
NB667 (). The percentage of remaining erythrocytes was calculated as follows: 100*(600 6 
nm absorbance of sample – absorbance of 100% lysis control) / (absorbance of 0% lysis 7 
control – absorbance of 100% lysis control). At the end of the reaction period (60 min) the 8 
symbols that do not share a common letter are statistically different (p<0.05) according to 9 
the LSD mean comparison test. 10 
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